Takara Bio (4974 JP): FY23 Looks Uncertain as COVID-19 PCR Testing Number Decline Is Inevitable
With COVID-19 test demand declining and base business recovery is not on full swing, Takara Bio’s growth potential beyond FY22 seems to be uncertain.
419 Views
JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Mar 2022
A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-March 2022.
527 Views
PHC Holdings (6523 JP): Eyeing a Bigger Pie of Global Diabetes Management Solution
Ahead of the global launch on Senseonics’ next-generation implantable CGM in Q2 2022, we are bullish on the long-term growth prospect of PHC.
535 Views
JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Jan 2022
A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-January 2022.
503 Views
Asia Short Interest Weekly - Shorts Covered as Markets Melted Up
The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...
644 Views